Kemper Alex R, Wallace David K
Department of Pediatrics, Duke University, Durham, North Carolina, USA.
Pediatrics. 2007 Sep;120(3):527-31. doi: 10.1542/peds.2007-0378.
Neonatologists play a central role in identifying infants who require screening for retinopathy of prematurity and in coordinating screening and treatment when necessary. No previous study has evaluated neonatologists' practices or experiences related to these activities.
A national mail survey of a random sample of 300 neonatologists was conducted from September to November 2006.
The response rate was 62%. Nearly all (98%) of the respondents considered gestational age to identify infants for retinopathy of prematurity screening. However, only 19% used the currently recommended gestational age criterion of 30 weeks; instead, 6% used a lower, more-restrictive criterion, and 74% used a higher, more-inclusive criterion. Fewer respondents (77%) considered birth weight to identify infants for retinopathy of prematurity screening, most of whom (86%) used the current criterion of < or = 1500 g. Although more than one half (67%) of the respondents reported that pediatric ophthalmologists usually screen infants for retinopathy of prematurity in their NICU, nearly one half (46%) reported that retinal specialists provide treatment. Some (36%) reported that they have been unable to transfer a child to a NICU of lower acuity or closer to the child's home because there are no specialists available there for retinopathy of prematurity screening. Some (34%) also reported that they have needed to delay discharge because outpatient follow-up for either screening or treatment of retinopathy of prematurity is not available near the family's home.
We found variations in how children are identified for retinopathy of prematurity screening and how screening and treatment are provided. Future research is needed to understand how these variations affect visual outcomes and costs of care. Such work must also consider the impact of regional pediatric eye care workforce shortages on retinopathy of prematurity screening and treatment strategies.
新生儿科医生在识别需要进行早产儿视网膜病变筛查的婴儿以及在必要时协调筛查和治疗方面发挥着核心作用。此前尚无研究评估新生儿科医生与这些活动相关的做法或经验。
2006年9月至11月,对300名新生儿科医生进行了随机抽样的全国性邮寄调查。
回复率为62%。几乎所有(98%)的受访者认为应根据胎龄来确定进行早产儿视网膜病变筛查的婴儿。然而,只有19%的人使用目前推荐的30周胎龄标准;相反,6%的人使用更低、更严格的标准,74%的人使用更高、更宽松的标准。较少的受访者(77%)认为应根据出生体重来确定进行早产儿视网膜病变筛查的婴儿,其中大多数(86%)使用目前的标准即≤1500克。尽管超过一半(67%)的受访者报告称儿科眼科医生通常在新生儿重症监护病房为婴儿进行早产儿视网膜病变筛查,但近一半(46%)的受访者报告称视网膜专科医生提供治疗。一些人(36%)报告称,由于当地没有进行早产儿视网膜病变筛查的专科医生,他们无法将患儿转到较低级别或离家更近的新生儿重症监护病房。一些人(34%)还报告称,由于患儿家庭住所附近没有进行早产儿视网膜病变筛查或治疗的门诊随访服务,他们需要推迟出院。
我们发现,在确定进行早产儿视网膜病变筛查的儿童以及提供筛查和治疗的方式上存在差异。未来需要开展研究,以了解这些差异如何影响视力结果和护理成本。此类工作还必须考虑区域儿科眼科护理人员短缺对早产儿视网膜病变筛查和治疗策略的影响。